Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
BMC Cancer ; 14: 212, 2014 Mar 20.
Artículo en Inglés | MEDLINE | ID: mdl-24650245

RESUMEN

BACKGROUND: Cancer is the leading cause of deaths in the world. A widening disparity in cancer burden has emerged between high income and low-middle income countries. Closing this cancer divide is an ethical imperative but there is a dearth of data on cancer services from developing countries. METHODS: This was a multi-center, retrospective observational cohort study which enrolled women with breast cancer (BC) attending 8 participating cancer centers in Malaysia in 2011. All patients were followed up for 12 months from diagnosis to determine their access to therapies. We assess care performance using measures developed by Quality Oncology Practice Initiative, American Society of Clinical Oncology/National Comprehensive Cancer Network, American College of Surgeons' National Accreditation Program for Breast Centers as well as our local guideline. RESULTS: Seven hundred and fifty seven patients were included in the study; they represent about 20% of incident BC in Malaysia. Performance results were mixed. Late presentation was 40%. Access to diagnostic and breast surgery services were timely; the interval from presentation to tissue diagnosis was short (median = 9 days), and all who needed surgery could receive it with only a short wait (median = 11 days). Performance of radiation, chemo and hormonal therapy services showed that about 75 to 80% of patients could access these treatments timely, and those who could not were because they sought alternative treatment or they refused treatment. Access to Trastuzumab was limited to only 19% of eligible patients. CONCLUSIONS: These performance results are probably acceptable for a middle income country though far below the 95% or higher adherence rates routinely reported by centres in developed countries. High cost trastuzumab was inaccessible to this population without public funding support.


Asunto(s)
Neoplasias de la Mama/economía , Neoplasias de la Mama/epidemiología , Países en Desarrollo/economía , Salud Global/economía , Accesibilidad a los Servicios de Salud/economía , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias de la Mama/diagnóstico , Estudios de Cohortes , Femenino , Humanos , Malasia/epidemiología , Persona de Mediana Edad , Estudios Retrospectivos , Adulto Joven
2.
Jpn J Clin Oncol ; 41(5): 723-9, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21450718

RESUMEN

This forum discussed issues relating to the inclusion of cancer on the global health agenda, with the ultimate aim of achieving human security for all people. The forum discussed what methods are available to the cancer community in attempts to create a common data system for the rapidly growing Asian region. Discussions also focused on the preparations that can be made to consider and respond to the obstacles to the creation of an Asia-wide data and information network. It was also noted that in order to create a cancer information network, support would need to be provided to low- and middle-income countries and efforts made to ensure that data are comparable.


Asunto(s)
Política de Salud , Difusión de la Información , Cooperación Internacional , Neoplasias , Asia , Perfilación de la Expresión Génica , Salud Global , Política de Salud/tendencias , Prioridades en Salud , Accesibilidad a los Servicios de Salud , Necesidades y Demandas de Servicios de Salud , Humanos , Estilo de Vida , Informática Médica , Pediatría/tendencias , Análisis de Secuencia de ADN , Bancos de Tejidos/tendencias
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA